Guest guest Posted March 23, 2008 Report Share Posted March 23, 2008 peacefulmeow wrote: > Since beginning to take probiotics two > years ago, I have found that my immunity has greatly improved. I also > take vitamin D3, omega-3, and lysine. Since starting this protocol I > have not had a single cold (and I am a teacher exposed to hundreds of > kids). > > I was wondering if anyone else takes probiotics, and if so, have you > found them beneficial? > > , land > My Wife, as me a non Croner, is taking it for IBS. It is too early to tell if it is working as her IBS waxs and wans. but so far so good. Positive Dennis Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 23, 2008 Report Share Posted March 23, 2008 Hi : It would be helpful if we had objective tests for the effectiveness of immune function which could be used to measure changes in immune system effectiveness in response to various types of 'treatments', such as the probiotics you mention. Does anyone know of any? Rodney. >> Since beginning to take probiotics two> years ago, I have found that my immunity has greatly improved. I also> take vitamin D3, omega-3, and lysine. Since starting this protocol I> have not had a single cold (and I am a teacher exposed to hundreds of> kids).> > I was wondering if anyone else takes probiotics, and if so, have you> found them beneficial?> > , land> Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 25, 2008 Report Share Posted March 25, 2008 A daily probiotic capsule was found to enhance the activity of T cells: link: http://www.nutraingredients.com/news/ng.asp?id=83253 full text: Probiotics give endurance athletes' immune boost: study By ls 14/02/2008- Supplements of probiotics may boost the immune health of long distance runners, protecting them from respiratory illnesses, suggests a small study published today. A daily probiotic capsule was found to enhance the activity of T cells, key players in the immune system, report the researchers after following 20 elite, endurance athletes during four months of intensive winter training. " In combination with the recent report that L rhamonasus supplementation reduced the duration of gastrointestinal symptoms in marathon runners in the 2 weeks after the race [int J Sport Nutr Exer Metab, 2007, Vol. 17, pp. 352-363], our findings point to the potential benefits of this form of nutritional intervention, " wrote the authors led by Pyne from the Australian Institute of Sport. The study is published online ahead of print in the British Journal of Sports Medicine. Consumers are increasingly aware of the health benefits associated with probiotics, including improved intestinal health and immune system stimulation. Indeed, probiotics remains a major growth market. The European sector is set to more than triple in value over the next few years, according to Frost & Sullivan, to reach $137.9 million (€118.5m) in 2010. The new study adds to the body of science by reporting that the 'friendly' bacteria may also produce benefits in endurance athletes undergoing strenuous training, previously reported to be more susceptible to upper respiratory tract infection (URTI) linked to the role of strenuous exercise in suppressing the immune system. Pyne and co-workers recruited the athletes and randomly assigned them to receive either a daily probiotic supplement containing Lactobacillus fermentum or placebo. After 28 days of receiving either the probiotic or placebo, they received nothing for one month (washout period) before crossing over to the other intervention. By the end of the study all the athletes had each had the probiotic and placebo formulations. Athletic performance of the subjects was assessed using a treadmill, while blood samples were taken at regular intervals to measure the immune response. The length and severity of respiratory tract infections were recorded by the subjects themselves. The researchers report no difference in running performance as a result of placebo or probiotics supplementation. On the other hand, the number of days of symptoms of URTI was halved when the athletes took the probiotic, compared to placebo. Specifically, symptoms of URTI's lasted 30 days when receiving the Lactobacillus supplements, compared to 72 days while taking the placebo. The severity of the symptoms was also less when receiving probiotics, stated the researchers. The blood samples showed that blood levels of interferon gamma, an important component of the body's immune response, were doubled when the subjects received probiotics, compared to placebo. However, no significant differences were observed in levels of immunoglobulin A and immunoglobulin A1 in the saliva, or levels of interleukin (IL)4 and IL12. Pyne and co-workers report that the benefits appear to be mediated via an enhancement of the functioning T-lymphocyte function. They do state, however, that the specific mechanism remains unclear and that it was not possible to draw definitive conclusions from the findings of the current study. " Further investigations are required to determine whether the beneficial effects of probiotic administration can translate to both the general public and specialised populations like elite athletes, clinical conditions, immuno-compromised subjects, and military and industrial settings, " wrote Pyne and co-workers. " The finding of clinical benefits with probiotic supplementation in a small cohort of physically fit subjects, provides the basis for further studies examining the beneficial effects of L fermentum VRI-003 administration on immune function in both the general community and specific populations, " they concluded. Source: British Journal of Sports Medicine Published online ahead of print, doi 10.1136/bjsm.2007.044628 " Oral administration of the probiotic Lactobacillus fermentum VR1-003 and mucosal immunity in endurance athletes " Authors: A.J. , D.B. Pyne, P.U. Saunders, P.A. Fricker --- In , " Rodney " <perspect1111@...> wrote: > > > Hi : > > It would be helpful if we had objective tests for the effectiveness of > immune function which could be used to measure changes in immune system > effectiveness in response to various types of 'treatments', such as the > probiotics you mention. > > Does anyone know of any? > > Rodney. ________________________________________________________________________________\ ____ Looking for last minute shopping deals? Find them fast with Search. http://tools.search./newsearch/category.php?category=shopping Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 25, 2008 Report Share Posted March 25, 2008 Supplements of pre- and probiotics can reduce levels of biomarkers linked to oxidative stress: link: http://www.nutraingredients.com/news/ng.asp?id=82418 full text: Pre- and probiotic combo linked to better antioxidant status By ls 09/01/2008- Supplements of pre- and probiotics can reduce levels of biomarkers linked to oxidative stress, suggests new results from an EU study. The synbiotic formulation containing oligofructose prebiotics (Beneo-Orafti) and a mixture of Lactobacillus and Bifidobacterium probiotics was associated with a reduction in oxidation of LDL, linked to, amongst other things, the development of atherosclerosis or hardening of the arteries. " The improvement in biomarkers of anti-oxidative activity seen with the synbiotic supplementation in this study is promising and warrants further research, especially since high oxidative stress is known to cause harm to our bodies, " said Dr. Anne Franck, vice president of research and development at the Beneo-Group. Talking to NutraIngredients.com, Dr. Franck confirmed that this is the first time that a link between prebiotics (and synbiotics) and oxidative stress has been reported in humans, despite previous being demonstrated in rodents. Results of the study - the EU and MicroFunction Project - were presented recently at the University of Ulster at last year's Nutrition Society meeting and the abstract is published in Proceedings of the Nutrition Society. The full results - not seen by NutraIngredients.com - are set to be published in a peer-reviewed journal in the coming months, said Dr. Franck. The randomised, double-blind (cross-over), placebo-controlled trial included fifty-three healthy Estonian adults. The subjects were randomly assigned to receive either the daily supplements of oligofructose (Orafti P95, 6.6 g/day) and probiotics (Lactobacillus fermentum ME-3, Lactobacillus paracasei 8700:2 and Bifidobacterium longum 46) or placebo (maltodextrin) for three weeks. The researchers, from the University of Reading (UK), the University of Tartu (Estonia) and Orafti, report that the total antioxidant activity of the subjects receiving the synbiotic supplements was higher than the corresponding placebo subjects: 42.4 versus 41.9 per cent, respectively. Furthermore, levels of oxidation of LDL were reduced in the synbiotic group, compared to placebo, reported the researchers (12.6 compared to 14.6 micromoles, respectively. Faecal measures of bifidobacteria were also higher after synbiotic supplementation, compared to placebo, and the researchers report that these increases were more pronounced when baseline levels were low before starting supplementation. Significantly, higher faecal butyrate concentrations were reported with the synbiotic (10.0 vs. 8.1 mm for the placebo). " The improvement in antioxidative-stress biomarkers and the increase in both bifidobacteria and butyrate on ingestion of the test synbiotic in this prophylactic study may warrant further research in diseases in which oxidative stress plays a role (such as CVD) or in populations in which the gut microbiota composition has been disturbed, " concluded the researchers. Dr. Franck confirmed to this website that the company was continuing to support studies in this area, with a focus on obesity, metabolic syndrome and healthy ageing. The EU and MicroFunction Project was established through a network of extensive collaborations between eight partners from seven different countries, and supported by the European Commission. Source: Proceedings of the Nutrition Society 2007, Volume 66, Page 101A " Effects of a synbiotic on biomarkers of oxidative stress and faecal microbiota in healthy adults: results of a cross-over double-blind placebo-controlled trial " Authors: D.M.A. Saulnier, P. Hutt, M. Mikelsaar, D. Bosscher, G. Gibson, S. Kolida ________________________________________________________________________________\ ____ Never miss a thing. Make your home page. http://www./r/hs Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.